25.12.2014 Views

Objectives • New drug approval process • Pricing of new drugs • Off ...

Objectives • New drug approval process • Pricing of new drugs • Off ...

Objectives • New drug approval process • Pricing of new drugs • Off ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

3/15/13%<br />

Prescription Drug User Fee Act V –<br />

effective Oct 1 st 2012<br />

• FDA pledges to review 90% <strong>of</strong> NDAs within<br />

12 months<br />

• Expectation is that this increases # <strong>of</strong> first<br />

cycle <strong>approval</strong>s<br />

• Mid cycle and late-cycle review meetings<br />

with sponsors<br />

• Increased communication & transparency<br />

• Pre-submission meeting to ensure NDA/BLA<br />

completeness<br />

• User fees increase:<br />

• Application now $ 1.96 million (6.3% inc)<br />

9%

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!